|Bid||12.90 x 1100|
|Ask||14.39 x 1100|
|Day's range||14.21 - 14.76|
|52-week range||10.43 - 15.49|
|Beta (5Y monthly)||0.81|
|PE ratio (TTM)||11.96|
|Earnings date||26 Jan 2022 - 31 Jan 2022|
|Forward dividend & yield||0.20 (1.39%)|
|Ex-dividend date||03 Jan 2022|
|1y target est||15.83|
Investors are optimistic about STERIS' (STE) strong segmental performance and bullish 2022 outlook.
Strong segmental performances are driving the top line for STERIS (STE).
Steris (STE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).